Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / People / Ivor Elrifi
Person

Ivor Elrifi

Tracked across 3 events · 18 articles · First seen Apr 01, 2026 · Last active Jun 25, 2026

Sentiment
33
Attention
4
Events
3
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (3)
4 50
Tech
Tiziana Foralumab na-SPMS Clinical Data
Impact: Ivor Elrifi, CEO of Tiziana Life Sciences, expressed satisfaction with the positive data and the company's intention to advance the program toward approval, highlighting the drug's potential as a new treatment paradigm.
May 19, 2026 · 6 articles
4 50
Tech
Tiziana Doses Last INFORM-MS Patient
Impact: Ivor Elrifi, CEO of Tiziana Life Sciences, expressed enthusiasm for reaching this milestone, highlighting the company's strong execution and the potential of the novel intranasal approach.
Jun 25, 2026 · 6 articles
4 0
Tech
Tiziana Life Sciences' Foralumab Preclinical Data
Impact: Ivor Elrifi, CEO of Tiziana Life Sciences, expressed enthusiasm for the preclinical data, reinforcing the company's positive outlook.
Apr 16, 2026 · 6 articles
Relationships (2)
Tiziana Life Sciences ↔ Ivor Elrifi
Tiziana Life Sciences ↔ Ivor Elrifi
ERGEN INTELLIGENCE
Track Ivor Elrifi live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.